2006VaccineRequires access

Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax® challenge in vaccinia-naïve and vaccinia-immune individuals

Janie Parrino, Lewis McCurdy, Brenda Larkin, Ingelise J. Gordon, Steven E. Rucker, Mary E. Enama, Richard A. Koup, Mario Roederer, Robert T. Bailer, Zoe Moodie, Lin Gu, Lihan Yan, Barney S. Graham

Open publisher page 96 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 96 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Vaccinia, Modified vaccinia Ankara, Smallpox vaccine, Virology, Immunogenicity, Poxviridae, Vaccination, Immune system

Related papers

Back to paper searchBrowse research topicsOriginal source
Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax® challenge in vaccinia-naïve and vaccinia-immune individuals — Research Paper | ScholarLens